Aditi Ashok slips on final day, signs off with silver in women's golf
Hangzhou (PTI): Aditi Ashok's fortunes tumbled on the final day as she carded a topsy-turvy 73 to sign off with a silver for India's first medal in women's golf at the Asian Games here on Sunday.
Coming into the final day with a commanding seven-stroke lead, Aditi saw the advantage evaporate as she stumbled upon four bogeys and a double bogey against a lone birdie to slip to the second position.
The 25-year-old ended her campaign with a four-day aggregate of 17-under 271 as Thailand's Arpichaya Yubol held her nerves to produce her week's best card of 64 and claim the coveted gold medal.
Korea's Hyunjo Yoo, too, carded an improved 65 to win a bronze.
India's other two players, Pranavi Urs and Avani Prashanth, too struggled to bring home cards of 75 and 76 as the Indian women's team ended its campaign at the fourth place.
While the gold slipped out of her hands, it was still a creditable performance from the two-time Olympian from Bangalore, who had missed a medal by a whisker at the Tokyo Games after finishing fourth.
It was India's fourth individual medal in golf with Lakshman Singh and Shiv Kapur winning the gold in the 1982 and 2002 editions and Rajiv Mohta claiming a silver in New Delhi.
An Indian squad comprising Lakshman, Rajiv, Rishi Narain and Amit Luthra had won the team gold in 1982, while the country also won two team silver medals in 2006 and 2010 editions at Doha and Guangzhou.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
